Background: Infant respiratory distress remains a significant problem worldwide, leading to more than one million neonatal deaths each year. The cost, maintenance, energy, and personnel required to implement ventilators have proven to be a barrier in many resource-limited settings. To address these barriers, a nonelectric bubble noninvasive positive pressure ventilation (NIV) device was developed.
View Article and Find Full Text PDFRespiratory illnesses are a leading cause of infant mortality worldwide. Bubble CPAP is a simple and effective treatment for infants in respiratory distress. Across resource-limited settings, various bubble CPAP setups have been used with widely varying results.
View Article and Find Full Text PDFBackground: Neonatal respiratory distress results in > 1 million annual deaths worldwide. Bubble CPAP is a simple, effective, and widely used therapy for infants in respiratory distress. In low-resource settings, more advanced respiratory support is limited by cost, technical expertise, and sporadic electricity.
View Article and Find Full Text PDF